our mission, vision and purpose
Mission:
To connect healthcare innovation, investment and adoption, backing companies whose technology can reach the people who need it.
Vision:
A world where healthcare breakthroughs complete the full journey, from validation to investment to bedside, without dying in the gaps between.
Purpose:
To transform healthcare by asking the question the rest of the market skips. Will this actually be adopted?
Innovation alone creates nothing. Capital alone creates nothing. Adoption alone creates nothing. Value exists only where all three are bound together.
How we evaluate adoption
Gap
The unmet clinical need. Consequential, urgent, and unresolved today.
Resolution
Whether it resolves that need in real time, rapidly and accurately.
Onramp
Whether it can enter and scale inside real health systems.
Worth
Whether adoption converts into durable revenue and lasting value.
WHAT WE LOOK FOR
What we look for
Commercial traction
Revenue-generating companies at Seed and Series A with paying customers and evidence of repeat use. We do not invest at the idea stage.
Consequential problems.
Clinical and operational problems whose resolution changes outcomes, cost or access at scale.
Speed and accuracy at the point of care
Products that deliver a usable answer inside the clinical moment, not after it.
A credible route in
A defined path through procurement, governance, workflow and reimbursement.
Evidence that travels. Validation that predicts performance in the next health system, not only the first.
Values
Give First. Lead with generosity. Trust the return.
Stay in the Trenches. We are in it with you.
Back What Gets Adopted. We invest in what reaches the world.
Bridge Worlds. Clinical and commercial. Capital and care.
Play the Long Game. Relationships over transactions.
Human First. Behind every solution is a life.
MD, MBA
Dr. Mohammed Quadri brings more than two decades of experience across healthcare strategy, clinical research, innovation and enterprise transformation, combining senior-level strategic leadership with hands-on execution.
His work has spanned ambulatory growth, research infrastructure, clinical innovation, value-based care, strategic partnerships and the development of new healthcare delivery models. This inside-healthcare perspective has given him a practical understanding of why promising technologies often struggle to move beyond validation, and what must be aligned across clinical workflow, institutional priorities, governance and commercial strategy for adoption to succeed.
Alongside his healthcare leadership, Dr. Quadri is a venture capital fellow, health technology investor and founder of StrideAI and HealCue. As Chairman of GrowQ360, he works at the intersection of clinical insight, capital and execution to help healthcare innovations progress from invention to adoption and measurable real-world value.
LEADERSHIP
Guiding strategy through experience and insight.
Dianne Aroh
EdD, NEA-BC, FACHE
Chief Clinical Adoption Officer and Chair of Adoption
Dianne Aroh is the inaugural Chief Clinical Adoption Officer at GrowQ360 Venture Fund, where she leads the firm’s clinical adoption work: carrying validated healthcare innovation from approval into everyday practice at the bedside.
She brings more than three decades of senior nursing and clinical operations leadership across major U.S. academic health systems. Most recently she served as Senior Vice President and Chief Nursing Officer of The Mount Sinai Hospital and Mount Sinai Queens, accountable for nearly 4,400 nursing FTEs and a budget exceeding $500 million. Earlier she was Senior Vice President and Chief Nursing Officer at Virginia Mason Franciscan Health, part of CommonSpirit Health; Executive Vice President, Chief Clinical and Patient Care Officer at Hackensack Meridian Health; and Vice President and Chief Nurse Executive at Montefiore Health System. Across these roles she became known for pairing measurable quality and safety outcomes with the management systems that sustain them, grounded in Leader Standard Work and Lean methodology.
Dianne holds a Doctor of Education in Organizational Change and Leadership from the University of Southern California’s Rossier School of Education and a Master of Science in Nursing Administration from Pace University. She is a registered nurse, board certified as a Nurse Executive, Advanced (NEA-BC), and a Fellow of the American College of Healthcare Executives (FACHE).
Bilal Mohammed
Chief of Staff
Bilal Mohammed is Chief of Staff at GrowQ360, where he works directly alongside the Founder and General Partner to turn strategy into execution across the fund and its portfolio.
His remit spans investor relations, strategic partnerships, and the operating infrastructure that sits underneath both. He leads institutional communications to limited partners and allocators, builds and manages the fund's partnership channels across healthcare, government, and family office networks, and drives the diligence and deal support work that moves opportunities from first conversation to committed capital.
Zahid Ali
Chief Al Officer
Zahid Ali is a healthcare technology and digital transformation leader with more than two decades of experience across healthcare IT, data, artificial intelligence and technology-enabled care delivery. He has held senior digital and information leadership roles and has worked with healthcare organisations, public-health programmes and innovation ecosystems internationally.
His experience includes electronic health records, interoperability, digital-health strategy, artificial intelligence, automation and the development of technology models designed to improve healthcare access and adoption. Zahid has been recognised by HIMSS as a Future50 Health IT Leader and has contributed to healthcare innovation initiatives involving health systems, global accelerators and technology ventures.
As Chief AI Officer at GrowQ360, Zahid supports the Fund’s technical assessment of healthcare AI companies, including the durability, clinical relevance, scalability and real-world adoptability of their technology.
Dr. Yavuz Selim Sılay
MD, MBA
Chief Global Relations Officer
Dr. Yavuz Selim Sılay is a physician, investor and international ecosystem builder with more than two decades of experience across healthcare, pharmaceuticals, investment and technology commercialization.
At GrowQ360, he leads global relationships and the Global Innovation and Adoption Collaborative, building partnerships among health systems, governments, universities, investors and founders across Türkiye, the Middle East, Africa and Europe. His previous work spans pharmaceutical leadership, market access, government engagement and the development of international healthcare and investment ecosystems.
Dr. Sheikh Mateen Ellahi
UK Strategy and Adoption Enablement
Dr. Sheikh Mateen Ellahi is a UK general practitioner, GP partner and clinical educator with experience spanning primary care, healthcare innovation and real-world technology adoption. He trains GPs and advanced clinical practitioners and contributes to medical education.
At GrowQ360, he leads UK Strategy and Adoption Enablement, helping evaluate how healthcare technologies can meet NHS clinical, governance and adoption requirements and establish credible pathways into frontline care. His work connects clinical judgment with GrowQ360’s adoption-led investment model.
Srinu Raghu
Head Security Advisor
Technology executive and board advisor with 15+ years of experience leading global engineering organizations across Fortune-scale enterprises, high-growth companies, and startups. Expertise spans AI and GenAI strategy, cloud and digital transformation, cybersecurity and fraud prevention, and building high-performing technology organizations at scale.
Experienced in translating technology strategy into business growth, operational efficiency, customer value, and effective risk management. Has served on and participated in advisory boards for emerging technology and growth-stage companies, advising on technology strategy, product development, organizational scaling, and market opportunities. Brings a strategic perspective at the intersection of technology, business, and innovation to help organizations navigate AI disruption, digital transformation, cybersecurity, and sustainable growth.
What we do not claim
There are no realised exits. GrowQ360 is a first-time institutional fund and says so plainly.
Company-provided metrics are labelled as such and are not independently verified. Platform capabilities in beta are described as beta.
The Fund has not yet begun investing. Companies shown reflect the General Partner’s sourcing, special purpose vehicles and pipeline, and are not current Fund holdings.
Any investor who requires a realised track record should not proceed, and we would rather say that here than three meetings from now.
Invest in the Future of Healthcare AI
Partner with a venture fund that treats adoption as the driver of growth, value creation and long-term outcomes.
